Literature DB >> 30919008

Pinacidil, a KATP channel opener, stimulates cardiac Na+/Ca2+ exchanger function through the NO/cGMP/PKG signaling pathway in guinea pig cardiac ventricular myocytes.

Keisuke Iguchi1,2, Masao Saotome1, Kanna Yamashita2, Prottoy Hasan1, Miyuki Sasaki2, Yuichiro Maekawa1, Yasuhide Watanabe3.   

Abstract

Pinacidil, a nonselective ATP-sensitive K+ (KATP) channel opener, has cardioprotective effects for hypertension, ischemia/reperfusion injury, and arrhythmia. This agent abolishes early afterdepolarizations, delayed afterdepolarizations (DADs), and abnormal automaticity in canine cardiac ventricular myocytes. DADs are well known to be caused by the Na+/Ca2+ exchange current (INCX). In this study, we used the whole-cell patch-clamp technique and Fura-2/AM (Ca2+-indicator) method to investigate the effect of pinacidil on INCX in isolated guinea pig cardiac ventricular myocytes. In the patch-clamp study, pinacidil enhanced INCX in a concentration-dependent manner. The half-maximal effective concentration values were 23.5 and 23.0 μM for the Ca2+ entry (outward) and Ca2+ exit (inward) components of INCX, respectively. The pinacidil-induced INCX increase was blocked by L-NAME, a nitric oxide (NO) synthase inhibitor, by ODQ, a soluble guanylate cyclase inhibitor, and by KT5823, a cyclic guanosine monophosphate (cGMP)-dependent protein kinase (PKG) inhibitor, but not by N-2-mercaptopropyonyl glycine (MPG), a reactive oxygen species (ROS) scavenger. Glibenclamide, a nonselective KATP channel inhibitor, blocked the pinacidil-induced INCX increase, while 5-HD, a selective mitochondria KATP channel inhibitor, did not. In the Fura-2/AM study pinacidil also enhanced intracellular Ca2+ concentration, which was inhibited by L-NAME, ODQ, KT5823, and glibenclamide, but not by MPG and 5-HD. Sildenafil, a phosphodiesterase 5 inhibitor, increased further the pinacidil-induced INCX increase. Sodium nitroprusside, a NO donor, also increased INCX. In conclusion, pinacidil may stimulate cardiac Na+/Ca2+ exchanger (NCX1) by opening plasma membrane KATP channels and activating the NO/cGMP/PKG signaling pathway.

Entities:  

Keywords:  Cardiac myocytes; Na+/Ca2+ exchange current (INCX); Nonselective KATP channel opener; Patch-clamp technique; Pinacidil

Year:  2019        PMID: 30919008     DOI: 10.1007/s00210-019-01642-1

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  40 in total

1.  Gliclazide scavenges hydroxyl, superoxide and nitric oxide radicals: an ESR study.

Authors:  Y Noda; A Mori; L Packer
Journal:  Res Commun Mol Pathol Pharmacol       Date:  1997-05

2.  ROS are required for rapid reactivation of Na+/Ca2+ exchanger in hypoxic reoxygenated guinea pig ventricular myocytes.

Authors:  B N Eigel; H Gursahani; R W Hadley
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-10-30       Impact factor: 4.733

3.  Grape seed proanthocyanidin extract alleviates urethral dysfunction in diabetic rats through modulating the NO-cGMP pathway.

Authors:  Bing Zhang; Zhaocun Zhang; Hong Ji; Hui Shi; Shouzhen Chen; Dongliang Yan; Xuewen Jiang; Benkang Shi
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

4.  Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels.

Authors:  M E Murphy; J E Brayden
Journal:  J Physiol       Date:  1995-07-01       Impact factor: 5.182

5.  Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization.

Authors:  L Carlsson; C Abrahamsson; L Drews; G Duker
Journal:  Circulation       Date:  1992-04       Impact factor: 29.690

6.  Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits.

Authors:  Y T Xuan; X L Tang; Y Qiu; S Banerjee; H Takano; H Han; R Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-11       Impact factor: 4.733

7.  Free radicals enhance Na+/Ca2+ exchange in ventricular myocytes.

Authors:  J I Goldhaber
Journal:  Am J Physiol       Date:  1996-09

8.  Regulation of the Na+/Ca2+ exchanger (NCX) in the murine embryonic heart.

Authors:  Michael Reppel; Bernd K Fleischmann; Hannes Reuter; Philipp Sasse; Heribert Schunkert; Jürgen Hescheler
Journal:  Cardiovasc Res       Date:  2007-03-28       Impact factor: 10.787

9.  Intracellular signalling mechanism responsible for modulation of sarcolemmal ATP-sensitive potassium channels by nitric oxide in ventricular cardiomyocytes.

Authors:  Dai-Min Zhang; Yongping Chai; Jeffrey R Erickson; Joan Heller Brown; Donald M Bers; Yu-Fung Lin
Journal:  J Physiol       Date:  2013-11-25       Impact factor: 5.182

10.  Activation of ATP-sensitive potassium channels facilitates the function of human endothelial colony-forming cells via Ca2+ /Akt/eNOS pathway.

Authors:  Yan Wu; Meng-Yu He; Jian-Kui Ye; Shu-Ying Ma; Wen Huang; Yong-Yue Wei; Hui Kong; Hong Wang; Xiao-Ning Zeng; Wei-Ping Xie
Journal:  J Cell Mol Med       Date:  2016-10-06       Impact factor: 5.310

View more
  4 in total

Review 1.  KATP channels in lymphatic function.

Authors:  Michael J Davis; Hae Jin Kim; Colin G Nichols
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-04       Impact factor: 5.282

Review 2.  Cardiac Na+/Ca2+ exchange stimulators among cardioprotective drugs.

Authors:  Yasuhide Watanabe
Journal:  J Physiol Sci       Date:  2019-10-29       Impact factor: 2.781

3.  Atherogenic L5 LDL induces cardiomyocyte apoptosis and inhibits KATP channels through CaMKII activation.

Authors:  Yanzhuo Ma; Nancy Cheng; Junping Sun; Jonathan Xuhai Lu; Shahrzad Abbasi; Geru Wu; An-Sheng Lee; Tatsuya Sawamura; Jie Cheng; Chu-Huang Chen; Yutao Xi
Journal:  Lipids Health Dis       Date:  2020-08-21       Impact factor: 3.876

Review 4.  Functional Regulation of KATP Channels and Mutant Insight Into Clinical Therapeutic Strategies in Cardiovascular Diseases.

Authors:  Zhicheng Wang; Weikang Bian; Yufeng Yan; Dai-Min Zhang
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.